Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations -?Richard Pascoe appointed Chairman of the Board of Directors to spearhead the ongoing business development discussions? https://lnkd.in/gi6XmdB
Seelos Therapeutics, Inc.
生物技术
New York，New York 2,938 位关注者
A clinical-stage biopharmaceutical company focused on central nervous system disorders and rare diseases.
关于我们
Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL".
- 网站
-
https://www.seelostherapeutics.com
Seelos Therapeutics, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- New York，New York
- 类型
- 上市公司
- 创立
- 2016
- 领域
- Rare Diseases、Parkinson's Disease、Sanfilippo Syndrome、Suicidality、Depression、PTSD、MDD、CNS Disorders、Pharmaceutical和ALS
地点
-
主要
获取路线
300 Park Avenue
2nd Floor
US，New York，New York，10022